Non-Compartmental Analysis (NCA)

ورودی‌های بالینی بیمار

حداقل ۰.۰۱ — حداکثر ۱۰۰۰۰۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
auc inf
—mg·h/L
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Computed0–0
Direct Clinical Answer

The Non-Compartmental Analysis (NCA) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include times. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Non-compartmental pharmacokinetic analysis from a concentration-time profile: AUC (linear trapezoidal with extrapolated tail), elimination rate constant Ke (log-linear regression on terminal points), half-life, clearance (Dose/AUC), and volume of distribution (CL/Ke). Enter times with concentrations; the last 3 points define the terminal phase by default.

Clinical Indication

The Non-Compartmental Analysis (NCA) is indicated for bedside clinical practice to support Non-compartmental pharmacokinetic analysis from a concentration-time profile: AUC (linear trapezoidal with extrapolated tail), elimination rate constant Ke (log-linear regression on terminal points), half-life, clearance (Dose/AUC), and volume of distribution (CL/Ke). Enter times with concentrations; the last 3 points define the terminal phase by default.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.

Limitations & Contraindications

Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.

Clinical Pearls & Action Plan

Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.

Formula & Variables:

AUC = trapezoidal + Clast/Ke; Ke = -slope(ln C vs t); CL = Dose/AUC; Vz = CL/Ke

Input Parameters

NameTypeRequiredDescription
timesarrayYesSample times in hours (comma-separated, increasing)
concentrationsarrayYesConcentrations at those times (comma-separated)
dosefloatYesDose administered in mg

Score Interpretation & Guidance

RangeStageDescription
0–0ComputedNCA parameters

Evidence-Based References (EBM)

  • Standard non-compartmental analysis: Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis. (trapezoidal AUC, terminal Ke, CL, Vz)

Related calculators